Catalyst Wire Dossier Catalyst Wire Dossier

TEIPP immunotherapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TEIPP immunotherapy, covering 2024-11-07 to 2024-11-07. Get the full timeline:

Most recent: Clinical Trial Update: TEIPP Immunotherapy in Patients With NSCLC [Phase 1, Phase 2]

See pricing